Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 322.0 | 73 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 348.0 | 67 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 452.5 | 56 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | GM-CSF | 429.0 | 75 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 336.0 | 75 | |
N2759 | TNF-a | 100 | ng/mL | 1 | GM-CSF | 395.5 | 50 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 438.0 | 66 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | GM-CSF | 446.5 | 82 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 379.0 | 67 | |
N2586 | TNF-a | 100 | ng/mL | 1 | GM-CSF | 381.0 | 72 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 234.5 | 68 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 243.5 | 58 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 229.5 | 66 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 237.0 | 64 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 217.5 | 74 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 247.5 | 68 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 215.0 | 52 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 222.0 | 59 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 386.5 | 72 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 381.0 | 57 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 344.0 | 66 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 373.5 | 58 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 353.0 | 58 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 358.0 | 55 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 403.0 | 45 |